// Workers AI · dad joke modeWhat did social dysfunction say to its therapist? It's not working together.
(Redirected from Social disorder)
Social dysfunction characterises a number of socially deficit mental disorders that affects social functioning.[1][2] Social dysfunction is a core symptom of social anxiety disorder (social phobia), autism, dementia, PTSD, schizophrenia and some personality disorders.[1][2][3]
Oxytocin receptor agonists, like oxytocin and LIT-001, and CA7 are of theoretical interest in the potential medical treatment of social dysfunction.[2][4][3]
References
[edit]- 1 2 Hrdlicka M, Dudova I (March 2013). "Controversies in autism: is a broader model of social disorders needed?". Child Adolesc Psychiatry Ment Health. 7 (1): 9. doi:10.1186/1753-2000-7-9. PMC 3606474. PMID 23506384.
- 1 2 3 Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (August 2011). "Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine". Nat Rev Neurosci. 12 (9): 524–38. doi:10.1038/nrn3044. PMID 21852800.
- 1 2 Spotlight Showcases: Kinoxis Therapeutics Pty Ltd. 5th Annual Neruoscience Innovation Forum for Business Development, Licensing & Investment 22nd–23rd March 2022, Digital Conference. March 2022.
Kinoxis' second series of compounds target the oxytocin receptor, through either selective partial agonism or positive allosteric modulation. The brain oxytocin system has been identified as perhaps the most important molecular target for regulating social behaviour and is therefore a major target of interest for treating a wide range of mental disorders. The development of these compounds will be focused on treating conditions that feature social dysfunction as a core symptom, such as neurodevelopmental disorders (including autism spectrum disorder), social anxiety disorder, dementia (including Alzheimer's disease), PTSD and schizophrenia. The KNX200 series of oxytocin receptor partial agonists are undergoing candidate selection stage using several pre-clinical animal disease models (Alzheimer's, PTSD, ASD) and the KNX300/400 series of oxytocin receptor positive allosteric modulators are undergoing lead optimisation.
- ↑ Hilfiger L, Zhao Q, Kerspern D, Inquimbert P, Andry V, Goumon Y, Darbon P, Hibert M, Charlet A (February 2020). "A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain". Sci Rep. 10 (1): 3017. doi:10.1038/s41598-020-59929-w. PMC 7033278. PMID 32080303.
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
 | This article about a mental disorder and related topics is a stub. You can help Wikipedia by adding missing information. |